Finance

Lists
Why is RTSN up 12.23%?
Dive Deeper
RTSN:NASDAQ
Retension Pharmaceuticals Inc.
$12.39
+12.23%
(+1.35) 1D
Nov 9, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RTSN...
Open
$10.96
High
$12.83
Low
$10.31
Mkt. cap
97.65M
Avg. vol.
98.04K
Volume
0.00
52-wk high
$18.64
52-wk low
$9.66
EPS
-$1.43
No. of employees
12
Open
$10.96
High
$12.83
Low
$10.31
Mkt. cap
97.65M
Avg. vol.
98.04K
Volume
0.00
52-wk high
$18.64
52-wk low
$9.66
EPS
-$1.43
No. of employees
12
News stories
From web sources and news partners
About Retension Pharmaceuticals Inc.
CEO-
Employees12
Founded2023
HeadquartersFalls Church, Virginia, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 2 analysts giving stock ratings to RTSN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RTSN in the last 3 months.
Highest
Current $12.39
$55.00 (+343.91%)
Average
$52.50 (+323.73%)
Lowest
$50.00 (+303.55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jay Olson
Oppenheimer
Buy
Initiated
$50.00
+303.6%
11/03/2026
Seamus Fernandez
Guggenheim
Buy
Initiated
$55.00
+343.9%
11/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.96M
1.96M
2.76M
3.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
421.16K
421.16K
736.83K
846.91K
Operating expense
2.39M
2.39M
3.50M
4.29M
Total operating expenses
2.39M
2.39M
3.50M
4.29M
Operating income
-2.39M
-2.39M
-3.50M
-4.29M
Other non operating income
-
-
-
-
EBT including unusual items
-2.21M
-2.21M
-3.35M
-4.17M
EBT excluding unusual items
-2.21M
-2.21M
-3.35M
-4.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.21M
-2.21M
-3.35M
-4.17M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
177.91K
177.91K
143.67K
118.51K
Interest expense
-
-
-
-
Net interest expenses
177.91K
177.91K
143.67K
118.51K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps